Welcome Message
Dear Esteemed Participants,
On behalf of the organizing committee, it is our great honor to welcome you to the 7th World Congress on Congestive Heart Failure & Angina, scheduled for April 26-27, 2027, in Paris, France.
This year’s congress gathers leading cardiologists, researchers, clinicians, industry innovators, and healthcare professionals from across the globe to share knowledge, present the latest scientific advancements, and collaborate on strategies to transform the prevention, diagnosis, and management of heart failure and angina. With cardiovascular diseases continuing to be the leading cause of mortality worldwide, this congress serves as a vital platform to address emerging therapies, technological breakthroughs, and patient-centered care.
Whether you are joining as a speaker, presenter, or delegate, we encourage you to engage actively, exchange perspectives, and foster new collaborations. Together, let us advance the science and practice of cardiovascular medicine and shape a healthier future.
We look forward to welcoming you to Paris for an enriching and unforgettable experience of learning, networking, and innovation.
Warm regards,
Organizing Committee
About Conference
The 7th World Congress on Congestive Heart Failure & Angina will be held on April 26-27, 2027 in Paris, France, bringing together global leaders, clinicians, scientists, researchers, and healthcare professionals to address the most pressing challenges in cardiovascular medicine. This premier event provides a dynamic forum for exchanging ideas, presenting cutting-edge research, and exploring the evolving landscape of cardiology.
The 2027 edition will spotlight a wide range of themes including pathophysiology of heart failure, advanced diagnostic tools, pharmacological and non-pharmacological therapies, interventional cardiology, regenerative medicine, and digital health innovations. With a comprehensive program of keynote lectures, symposia, oral and poster presentations, workshops, and panel discussions, the congress fosters collaboration between academia, industry, and clinical practice.
Whether you are a researcher driving new discoveries, a clinician enhancing patient outcomes, or an industry leader developing the next generation of cardiovascular solutions, this congress is your gateway to innovation and impact in the fight against heart failure and angina.
Conference Highlights
-
Advances in Heart Failure: Emerging Therapies and Treatment Strategies
-
Neurohormonal and Inflammatory Mechanisms in Cardiovascular Diseases
-
Metabolic Remodeling and Mitochondrial Dysfunction in Heart Failure
-
Coronary Microvascular Dysfunction and Ischemic Heart Disease
-
Myocardial Fibrosis, Cardiomyopathy, and Cardiac Remodeling
-
Pulmonary Hypertension and Right-Sided Heart Failure
-
Advanced Cardiac Imaging and Early Disease Detection
-
Artificial Intelligence in Cardiac Diagnostics and Predictive Imaging
-
Novel Cardiac Biomarkers and Multi-Omics Approaches
-
Non-Invasive Hemodynamic Monitoring and Wearable Cardiac Technologies
-
Precision Medicine and Personalized Cardiovascular Care
-
Gene Editing, RNA-Based Therapeutics, and Molecular Cardiology
-
Novel Immunomodulatory and Anti-Inflammatory Therapies
-
Advanced Lipid-Lowering and Antithrombotic Strategies
-
SGLT2 Inhibitors, GLP-1 Therapies, and Cardiovascular Outcomes
-
Cardiac Amyloidosis and Infiltrative Cardiomyopathies
-
Myocarditis and Inflammatory Heart Diseases
-
Cardiovascular-Kidney-Metabolic Syndrome and Multiorgan Interactions
-
Obesity, Diabetes, and Cardiovascular Risk Management
-
Advanced Heart Failure and Mechanical Circulatory Support
-
Transcatheter Valve Interventions and Structural Heart Disease
-
Arrhythmias and Next-Generation Electrophysiology
-
Cardiac Regeneration, Stem Cell Therapy, and Tissue Engineering
-
Digital Twins and Predictive Modeling in Cardiology
-
Remote Patient Monitoring and Digital Cardiac Rehabilitation
-
Cardiovascular Prevention and Lifestyle Medicine
-
Women's Cardiovascular Health and Pregnancy-Related Disorders
-
Sports Cardiology and Exercise-Related Cardiac Risk
-
Mental Health, Frailty, and Quality of Life in Cardiac Patients
-
Global Cardiovascular Health, Health Equity, and Palliative Care
Participation / Presentation Options
To ensure accessibility for global researchers and clinical professionals, the Summit offers multiple participation formats designed to support scientific exchange, visibility, and collaboration.
Oral Presentation: Showcase comprehensive studies, clinical trial outcomes, and novel cardiovascular biomarkers, advanced cardiac imaging techniques, heart-failure–focused diagnostics, or innovative therapeutic methodologies. Oral presenters will engage in interactive Q&A sessions with leading experts in cardiology, heart failure management, and ischemic heart disease research.
Poster Presentation: Ideal for early-stage studies, pilot data, method development, and exploratory work. Presenters engage with delegates during dedicated poster viewing and networking segments.
Virtual Presentation: A flexible option for participants unable to travel. Present your work online and receive equal recognition, certificates, and publication benefits as onsite presenters.
Delegate Participation: For professionals who wish to attend without presenting. Delegates gain full access to all scientific sessions, keynote talks, workshops, and networking activities.
Exhibitor & Sponsorship Opportunities: Designed for biotech firms, diagnostic companies, CROs, universities, and healthcare technology providers. Exhibitors can showcase products, services, and innovations to a global audience.
Market Analysis
The global cardiovascular market continues to grow rapidly, driven by the rising prevalence of heart failure, aging populations, and innovations in treatment and diagnostics.
The global heart failure therapeutics market is projected to surpass USD 20 billion by 2030, fueled by advances in drug therapies and device technologies.
The cardiac devices market (including pacemakers, defibrillators, and ventricular assist devices) is expected to grow steadily at a CAGR of over 6% through 2030.
Digital health and remote monitoring in cardiology are expanding significantly, offering opportunities for tele-cardiology, AI-driven diagnostics, and wearable devices.
Regenerative medicine and gene therapy are emerging as promising frontiers for advanced heart failure treatment.
Global initiatives for preventive cardiology and lifestyle-based interventions are increasing, with a focus on reducing healthcare costs and improving patient outcomes.
The congress provides a unique opportunity for stakeholders to align with market trends, foster partnerships, and accelerate progress in the global fight against heart failure and angina.
Abstract Review Process& VISA Process
Our abstract review process ensures academic rigor and fair evaluation:
Submission: Authors submit abstracts through the official online portal.
Pre-Screening: The editorial team verifies topic relevance, clarity, and structure.
Double-Blind Evaluation: Each abstract is reviewed by two independent experts specializing in gastroenterology and liver or related fields.
Scoring Criteria:
Decision & Notification: Accepted abstracts are assigned to Oral, Poster, or Virtual Presentation categories. Feedback and revision suggestions may be offered where applicable.
Early Acceptance Advantage: Early submissions are given priority in program scheduling, allowing authors to secure preferred presentation slots.
VISA Process
We support all international participants in successfully completing their visa application process. Once your registration is confirmed, the organizing committee will provide:
These documents assist in meeting the requirements of the French Embassy or Consulate in your region.
General Visa Requirements
Participants may be asked to provide:
We strongly recommend applying 6–8 weeks in advance to avoid last-minute complications.
In Case of Visa Rejection: Refund & Participation Options:
We understand that visa outcomes vary from country to country. Therefore, our policy is designed to support you:
If your visa is rejected, you may switch to Virtual Presentation or Virtual Participation without any deduction.
If you prefer to request a refund, the organizing committee will process it after receiving the official visa rejection letter from the embassy or consulate.
Refund requests must be submitted within 10 days of receiving the rejection notice.
Processing timelines for refunds are typically 2–3 weeks.
Registration can also be transferred to the next edition of the conference without additional fees if preferred.
This ensures that your research and contribution remain part of the scientific program—even if you cannot travel physically.
CONFERENCE AGENDA
Registration & Kit Collection: Delegates will begin with registration, receiving ID badges, conference kits, and the full agenda. On-site staff will be available to assist with any queries. Early arrival is encouraged.
Inaugural Session & Opening Remarks: The congress opens with a welcome note from the organizing committee, followed by keynote addresses from distinguished cardiology experts. A group photograph will conclude the session.
Scientific Sessions & Presentations: Parallel tracks will cover specialized topics, from biomarkers and imaging in heart failure to surgical interventions and lifestyle medicine. Oral, poster, and e-poster presentations will provide opportunities for participants to showcase their work.
Networking Breaks & Poster Walks: Tea/coffee breaks and poster sessions will allow attendees to interact, share feedback, and connect with peers and exhibitors.
Conference Lunch & Awards Ceremony: Delegates will enjoy networking luncheons. On the final day, awards for best oral and poster presentations will be presented, along with certificates and closing remarks.
Optional Activities: Delegates may join guided city tours or special networking dinners to explore Paris and build professional relationships.